ChartMill assigns a Buy % Consensus number of 80% to IGC. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-26 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-03-06 | Alliance Global Partners | Reiterate | Buy -> Buy |
| 2025-02-24 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-12-05 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-09-03 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-07-29 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-07-17 | Alliance Global Partners | Initiate | Buy |
| 2024-06-21 | Ascendiant Capital | Reiterate | Buy -> Buy |
5 analysts have analysed IGC and the average price target is 3.7 USD. This implies a price increase of 1058.73% is expected in the next year compared to the current price of 0.3191.
The consensus rating for IGC PHARMA INC (IGC) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering IGC PHARMA INC (IGC) is 5.